PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “ERYTHROPOIESIS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 991 records · Page 55Linked to original sources

Dietary restriction augments erythropoiesis in mice.

Previously, we have reported that a 40% dietary restriction caused microcytic and short-lived erythrocytes without anemia in mice (Internat. J. Vitr. Nutr. Res. (1989) 59, 406-412). To elucidate the mechanism of these phenomena, the effects of dietary restriction on the proliferation of erythroid precursor cells were investigated. In the diet restricted mice, a striking increase of erythropoietin (EP - responsive erythroid precursor cells without increment of EP was observed. Remarkable increases in the numbers of femoral nucleated cells and erythroid stem cells (CFU-S) were also observed in the diet restricted mice. Furthermore, the percentage of femoral CFU-S in DNA synthetic stage (S phase) revealed remarkably higher levels in the diet restricted mice than in the control mice. Our results strongly suggest that the microcytic change of erythrocytes in the diet restricted mice may be attributed to the increased number of erythroid precursor cells without an increment of hemoglobin synthesis and that the avoidance of becoming anemic from the short-lived erythrocytes in the diet restricted mice may be caused by a vigorous erythropoiesis.

Anemia↗

[Regulation of erythropoiesis: recent progress and current uncertainties].

Rapid progress has occurred recently in characterizing the molecular structure of the glycoproteins controlling the growth, maturation and functional activities of hematopoietic cells. Several of these factors have been purified and cDNAs have been cloned, providing them in sufficient quantities for study and eventual clinical use. Both availability of these molecules and in vitro colony assays have revealed a large number of effects on erythroid differentiation. But, except erythropoietin (EPO), the physiological role of these hormones and their relative contributions to normal erythropoiesis remain to be specified. This paper attempts to review the most important data on this topic in 1990.

Animals↗

Synergistic effects of T-2 toxin and a low protein diet on erythropoiesis in mice.

Young male Swiss mice fed on a semipurified diet containing 8% protein and 10 ppm of T-2 toxin developed erythroid hypoplasia within 2 weeks. Red blood cell counts declined to 36% of control values by 6 weeks but had risen to 45% of control values by 8 weeks. Between 4 and 8 weeks, erythropoietic tissues regenerated and reticulocyte counts became greatly elevated. The toxin-free semipurified diet was adequate for normal growth and did not cause anemia in control mice fed either ad lib, or at a restricted rate. Anemia did not occur in mice fed the 10-ppm level to T-2 toxin in either a semipurified diet containing 16% protein, or in a balanced natural-ingredient mouse diet. These observations demonstrated that the inhibitory effect of T-2 toxin in erythropoiesis in mice was transient, and depended on the nutritional composition of the diet.

Animals↗

In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.

Erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes (MDS) was evaluated by measuring the in vitro response of primitive (BFU-E) and relatively mature (CFU-E) erythroid progenitors from 12 patients and from eight healthy donors to recombinant human erythropoietin (rhEPO), and by quantifying relationships between circulating EPO levels and progenitor cell frequencies in MDS marrow. Half-maximal growth of MDS CFU-E and BFU-E was detected at a 4-fold higher rhEPO concentration than required by control erythroid progenitors. Nine of the patients evaluated exhibited maximal growth of erythroid colonies at 5- to 20-fold higher than control saturating rhEPO concentrations. Circulating EPO levels in MDS patients were elevated, with a mean value approximately 35-fold higher than that of controls. The frequency of MDS marrow CFU-E and BFU-E was 57 +/- 42% and 18 +/- 9% of the mean control values, respectively. Correlation analysis of the relationships between MDS EPO levels and erythroid progenitors indicated that the anemia in MDS is not attributable to an abnormality in the capacity of EPO to induce the generation of CFU-E, but may be influenced by the BFU-E population, whose severe deficiency results in insufficient influx of EPO-responsive cells. Our findings therefore suggest that treatment of MDS patients with rhEPO may be of limited benefit, since the generation of BFU-E from more primitive ancestors and the initial growth requirements of these cells are not under the regulatory influence of this hormone.

Adolescent↗

Erythropoiesis in murine long-term marrow cultures following transfer of the erythropoietin cDNA into marrow stromal cells.

Long-term bone marrow cultures (LTMC) have provided a useful in vitro system to study stem cell self-renewal and myeloid differentiation. However, standard murine LTMC are devoid of erythroid differentiation within 2 weeks of establishment. In an attempt to develop a model system to study erythropoiesis in vitro, we have used a recombinant retrovirus vector to transfer the erythropoietin cDNA into stromal cells making up the hematopoietic microenvironment of murine LTMC. Three weeks after infection, erythroid differentiation was evident macroscopically, with clumps of hemoglobinized red blood cells present in the infected cultures. Hemoglobinization was confirmed by benzidine staining of nonadherent cells, which showed that up to 70% of nucleated cells were benzidine positive. In combination with LTMC, the use of recombinant retrovirus vectors to transfer growth factor genes may provide useful models to study the interactions of hematopoietic stem cells, hematopoietic microenvironment, and growth factors in vitro.

Animals↗

[Perioperative anemia and erythropoiesis].

50 consecutive patients with hip arthroplasty had acute normovolaemic haemodilution and intra- and postoperative autotransfusion using Autotrans, Dideco GmbH. 18 of 50 patients received homologous blood products additionally to autotransfusion (Hb less than 8 g/dl, hemodynamic instability). There was no evidence for coagulation disorders, hypoxia or hypovolaemia during the whole investigation period (until the 10th p.o. day) though in some cases haemoglobin-levels less than 7 g% were accepted. No variations of erythropoietin levels could be observed postoperatively, suggesting that acute anaemia alone does not affect erythropoiesis. Reticulocytes, however, increased significantly from the 4th postoperative day. There was no correlation between number of reticulocytes and erythropoietin levels. Lactate levels stayed within normal range during the whole investigation period thus indicating normal microcirculation. The present data demonstrate that postoperative anaemia can be tolerated even in elder patients if intravascular volume is kept constant (normovolaemia). In accordance with recent literature the course of erythropoietin levels seemed to prove that there was no functional reduction in oxygen-availability.

Anemia↗

[Effect of erythropoiesis, size of iron accumulation and oxygen saturation of tissues on iron resorption].

The volume of iron resorption is altered by numerous factors. To a wide extent, the exact regulating mechanisms have not been elucidated to the present day. The present paper deals with representing the influence of iron resorption by erythropoiesis, filling condition of iron stores and oxygen saturation of the tissue as well as with main aspects which are relevant for future research.

Absorption↗

[The red blood cells in growing guinea pigs. (Cavia cobaya). II. Communication: erythropoiesis and red blood cells in the postnatal development period].

Bone-marrow smears of 175 guinea pigs aged 1-27 days and venous blood samples of 351 animals aged 1-25 days were prepared for cell counting. A significant increase of erythroblasts were found between life day 1 and 2; normoblasts increased in number synchronously with a decrease of erythroblasts after the 5th day. The percentage of the erythroid bone marrow increased from 10 to 14 during the developmental period. Beyond the perinatal period the red blood picture is characterized by the following changes: a decrease of erythrocyte count, hematocrit, hemoglobin, mean corpuscular volume, and mean corpuscular hemoglobin; a constant mean corpuscular hemoglobin concentration; an increase of the reticulocyte count. The decrease of the red cell count is compensated by a decreasing oxygen affinity attained by an important increase of 2,3-DPG. Nevertheless, the stimulus for a raising erythropoiesis remains constant which can be shown by the growing percentage of erythroid cells and reticulocytes. The difference between the human postnatal development and that of the guinea pig becomes obvious. Cell counts in dependence of body masses in postnatally growing guinea pigs, veil the perinatal finding of the increase in erythrocytes up to the 5th day and the decrease of the mean corpuscular volume after the 3rd day.

Animals↗

[High molecular substances in relation to disorders of erythropoiesis in patients in the terminal stage of chronic renal failure].

Fraction F1 with a MW of 5.10(3)-5.10(4), which had been isolated from the blood serum of blood donors as controls and patients at the terminal stage of chronic kidney insufficiency, specifically inhibited the erythropoiesis of test animals at the stage sensitive to erythropoietin and morphologically distinguishable cells of the bone-marrow. In uremia, protein concentration was twice higher in comparison to the normal one. The inhibiting effect of fraction F1 from the serum of patients is caused by the enlargement of level of physiological inhibitors and unspecific toxins of the cell proliferation. Those data characterising the factor detected in the fraction F1 of normal serum together with the erythrocytic chalon are discussed.

Adolescent↗

The initiation of erythropoiesis following renal transplantation.

Erythropoiesis has been examined in relation to kidney function in 38 patients during the 3-month period following successful renal transplantation, using serial determinations of erythropoietin, haemoglobin, and creatinine. Two peaks of serum erythropoietin were observed: an early peak that occurred within 2 days of transplantation and was observed in ten patients, and a late one between 8 and 30 days, observed in 28 patients. The early peak did not produce an increase in haemoglobin and occurred only in the presence of delayed onset of graft excretory function when serum creatinine was greater than 1000 mumols/l. The ineffectiveness of the early peak may be due to the uraemic environment, which is probably a sequel of the tubular damage associated with postoperative acute tubular necrosis. The late peak followed a decrease in serum creatinine to less than 200 mumols/l and was associated with an increase in haemoglobin of 3-4 g/dl during the next 2-6 weeks.

Adolescent↗

[Humoral regulators of erythropoiesis during the body's adaptation to chronic respiratory insufficiency].

It was revealed during examination of 91 patients with chronic nonspecific lung diseases for the blood titers of erythropoietin, erythrocytic chalones, erythrocyte hemolysis products and medium molecules that in the stage I respiratory failure, there were no material changes in the titres of erythrocyte hemolysis products, erythropoietin and medium molecules, whereas the titer of erythrocytic chalones appeared to be high. Stage III of the disease was also marked by no changes in the titer of erythrocyte hemolysis products. However, the titers of erythropoietin and medium molecules rose whereas the titer of erythrocytic chalones was reduced. In the stage II respiratory failure, the above enumerated factors of humoral regulation of erythropoiesis appeared similar to those in stage I. These data evidence that different compensatory reactions to hypoxia associated with chronic respiratory failure are implicated at the molecular, cellular and systemic levels. The up-to-date treatment and diagnostic process is not feasible, provided these reactions are not taken into consideration.

Adaptation, Physiological↗

[Erythropoiesis inhibitor in the plasma of patients with hemopoietic dysplasias].

Altogether 21 patients were examined for an erythropoiesis inhibitor contained by the IgG fraction of the blood plasma. All these patients suffered from hemopoiesis depression. The inhibitor identified in the immunoglobulin fraction of the blood plasma of 40% of the patients manifested itself at the stage of erythroid precursors of bone marrow cells. The role of the humoral inhibitor in the development of erythropoietic disorders in these patients is under discussion.

Animals↗

[Erythropoiesis and erythrocytes in children, physiology and standards].

Foetal erythropoiesis has its own particularities: it takes place mostly in the liver for a long time, is macrocytic and is strongly stimulated, then suppressed at birth; the level of haemoglobin F, which has specific properties, is still high at birth. In children, the site of sampling must be clearly indicated in view of possible discrepancies between capillary and venous blood samples. Hemoglobin levels and red cell indices vary with age, and it is indispensable to take as reference standards that change in each period of life from foetal life to adolescence. The polycythaemia and macrocytosis observed at birth is followed by a period when the haemoglobin level is relatively low and microcytosis develops. Adult values will be reached gradually during the second part of childhood.

Age Factors↗

[Changes in the number and size of fibrillar centers in nucleolus inactivation during erythropoiesis].

The size and number of fibrillar centers (FCs) was shown to be proportional to or correlate with the ploidy of the cell, respectively. In the active nucleoli of erythroblasts, the numbers of FCs exceeds several-fold that of nucleoli organizing regions (NORs). In the course of maturation, the number of FCs becomes 3-10 times lower than that of NORs. The total size of FCs decreases three-fold during differentiation, although the size of individual FCs increases. Inactivation of ribosomal genes in the process of erythropoiesis seems to be accompanied by fusion of individual FCs and compaction of their tissue.

Animals↗

Identification and characterization of an 8-kd peptide stimulating late erythropoiesis.

Chronic renal failure is often associated with severe anemia, subnormal levels of erythropoietin (EPO), and the presence of erythropoietic inhibitors. We studied an anephric patient with polycystic kidney disease maintaining a hemoglobin level of 13-14 g. Biochemical, endocrine, and hematological parameters were all within normal limits. EPO levels examined on two occasions during the clinical investigation were found to be low to subnormal. Plasma of this patient supported human bone marrow erythroid colony formation without the addition of exogenous EPO. Following reversed-phase high pressure liquid chromatography (HPLC) and gel filtration HPLC of the patient's plasma, a small polypeptide was identified that stimulated thymidine incorporation into fetal calf liver cells and supported erythroid colony formation of human marrow cells. This molecule is different from EPO with respect to its molecular weight and its functional and chromatographic properties. In this report we provide evidence of a human plasma-derived peptide of an anephric patient regulating late erythropoiesis.

Blood Proteins↗

[Changes in the biochemical indices in iron-deficiency erythropoiesis].

In 608 patients with iron-deficiency anemia the following indices were examined: serum iron, total iron-binding capacity, serum ferritin, hemoglobin, free protoporphyrin, reduced glutathione as well as the activity of porphobilinogen synthetase in the erythrocytes. Increased of free protoporphyrin and of reduces glutathione as well as increased activity of porphobilinogen synthetase were found which the authors accept as an expression of iron-deficiency erythropoiesis. Serum ferritin was lowered but in many patients its level did not indicate totally exhausted iron reserves despite the well expressed anemia accompanied by a low serum iron level and transferrin saturation. In these patients an additional pathogenetic mechanism is supposed leading to retaining of some quantity of iron in the cells of the monocytic-macrophagal system.

Adult↗

Neuropeptide modulation of murine erythropoiesis.

Neuropeptide modulation of hematopoietic stem cell differentiation was studied in an in vitro murine system. Endorphins were able to influence the erythropoietin-dependent differentiation of bone marrow cells into erythroid colony forming units in a dose dependent manner. The effects on progenitor cell maturation were influenced by the conditions and time of exposure to the endorphins. The modulation of erythropoiesis by the endorphins suggests that these peptides may function as modifiers of the maturation of bone marrow cells.

Adrenocorticotropic Hormone↗